Some targets have been reported in the current literature as being potentially important and effective targets for COVID-19 treatment (in addition to drugs that could modulate the effects of cytokines), like HDAC2/344,45, JAK246, CDK247, AKT148, MDM249, TNF50, MAPK1417, STAT351, BCL252, NFKB1A53, EGFR51. The gene discussed is HDAC2; the disease is COVID-19.